Cargando…
Novel Platforms for Biomedical HIV Prevention Delivery to Key Populations — Community Mobile Clinics, Peer-Supported, Pharmacy-Led PrEP Delivery, and the Use of Telemedicine
PURPOSE OF REVIEW: A gap exists between PrEP interest and PrEP uptake in key populations (KP) for HIV prevention that may be ascribed to PrEP delivery services not being acceptable. This review summarizes novel platforms for HIV prevention outside of the traditional health facilities environment. RE...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8549812/ https://www.ncbi.nlm.nih.gov/pubmed/34708316 http://dx.doi.org/10.1007/s11904-021-00578-7 |
_version_ | 1784590843864154112 |
---|---|
author | Rousseau, E. Julies, R. F. Madubela, N. Kassim, S. |
author_facet | Rousseau, E. Julies, R. F. Madubela, N. Kassim, S. |
author_sort | Rousseau, E. |
collection | PubMed |
description | PURPOSE OF REVIEW: A gap exists between PrEP interest and PrEP uptake in key populations (KP) for HIV prevention that may be ascribed to PrEP delivery services not being acceptable. This review summarizes novel platforms for HIV prevention outside of the traditional health facilities environment. RECENT FINDINGS: Mobile health clinics provide highly acceptable integrated, KP-focused services at convenient locations with the potential of high PrEP uptake. Telemedicine and health apps decongest health systems and allow for personal agency and informed decision-making on personal health. Pharmacy-led PrEP delivery provides de-medicalized, confidential PrEP services at extended hours in community locations, from trusted medical professionals. Peer-supported delivery encourages continued PrEP use. SUMMARY: Community-based, differentiated and de-medicalized PrEP delivery can address uptake and continued use barriers in key populations. Future research should assess scalability, cost-effectiveness and sustainability of these PrEP delivery platforms, as well as focus on ways to simplify PrEP provision. |
format | Online Article Text |
id | pubmed-8549812 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Springer US |
record_format | MEDLINE/PubMed |
spelling | pubmed-85498122021-10-28 Novel Platforms for Biomedical HIV Prevention Delivery to Key Populations — Community Mobile Clinics, Peer-Supported, Pharmacy-Led PrEP Delivery, and the Use of Telemedicine Rousseau, E. Julies, R. F. Madubela, N. Kassim, S. Curr HIV/AIDS Rep The Science of Prevention (R Heffron and K Ngure, Section Editors) PURPOSE OF REVIEW: A gap exists between PrEP interest and PrEP uptake in key populations (KP) for HIV prevention that may be ascribed to PrEP delivery services not being acceptable. This review summarizes novel platforms for HIV prevention outside of the traditional health facilities environment. RECENT FINDINGS: Mobile health clinics provide highly acceptable integrated, KP-focused services at convenient locations with the potential of high PrEP uptake. Telemedicine and health apps decongest health systems and allow for personal agency and informed decision-making on personal health. Pharmacy-led PrEP delivery provides de-medicalized, confidential PrEP services at extended hours in community locations, from trusted medical professionals. Peer-supported delivery encourages continued PrEP use. SUMMARY: Community-based, differentiated and de-medicalized PrEP delivery can address uptake and continued use barriers in key populations. Future research should assess scalability, cost-effectiveness and sustainability of these PrEP delivery platforms, as well as focus on ways to simplify PrEP provision. Springer US 2021-10-27 2021 /pmc/articles/PMC8549812/ /pubmed/34708316 http://dx.doi.org/10.1007/s11904-021-00578-7 Text en © The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature 2021 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic. |
spellingShingle | The Science of Prevention (R Heffron and K Ngure, Section Editors) Rousseau, E. Julies, R. F. Madubela, N. Kassim, S. Novel Platforms for Biomedical HIV Prevention Delivery to Key Populations — Community Mobile Clinics, Peer-Supported, Pharmacy-Led PrEP Delivery, and the Use of Telemedicine |
title | Novel Platforms for Biomedical HIV Prevention Delivery to Key Populations — Community Mobile Clinics, Peer-Supported, Pharmacy-Led PrEP Delivery, and the Use of Telemedicine |
title_full | Novel Platforms for Biomedical HIV Prevention Delivery to Key Populations — Community Mobile Clinics, Peer-Supported, Pharmacy-Led PrEP Delivery, and the Use of Telemedicine |
title_fullStr | Novel Platforms for Biomedical HIV Prevention Delivery to Key Populations — Community Mobile Clinics, Peer-Supported, Pharmacy-Led PrEP Delivery, and the Use of Telemedicine |
title_full_unstemmed | Novel Platforms for Biomedical HIV Prevention Delivery to Key Populations — Community Mobile Clinics, Peer-Supported, Pharmacy-Led PrEP Delivery, and the Use of Telemedicine |
title_short | Novel Platforms for Biomedical HIV Prevention Delivery to Key Populations — Community Mobile Clinics, Peer-Supported, Pharmacy-Led PrEP Delivery, and the Use of Telemedicine |
title_sort | novel platforms for biomedical hiv prevention delivery to key populations — community mobile clinics, peer-supported, pharmacy-led prep delivery, and the use of telemedicine |
topic | The Science of Prevention (R Heffron and K Ngure, Section Editors) |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8549812/ https://www.ncbi.nlm.nih.gov/pubmed/34708316 http://dx.doi.org/10.1007/s11904-021-00578-7 |
work_keys_str_mv | AT rousseaue novelplatformsforbiomedicalhivpreventiondeliverytokeypopulationscommunitymobileclinicspeersupportedpharmacyledprepdeliveryandtheuseoftelemedicine AT juliesrf novelplatformsforbiomedicalhivpreventiondeliverytokeypopulationscommunitymobileclinicspeersupportedpharmacyledprepdeliveryandtheuseoftelemedicine AT madubelan novelplatformsforbiomedicalhivpreventiondeliverytokeypopulationscommunitymobileclinicspeersupportedpharmacyledprepdeliveryandtheuseoftelemedicine AT kassims novelplatformsforbiomedicalhivpreventiondeliverytokeypopulationscommunitymobileclinicspeersupportedpharmacyledprepdeliveryandtheuseoftelemedicine |